SCHEMBL25878364

SCHEMBL25878364

c1ccc(-c2nc(-c3ccc(-c4ccccn4)cc3)nc(-c3cccc4c3C3(c5cc(-c6ccc7oc8ccccc8c7c6)ccc5-4)C4CC5CC(C4)CC3C5)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPK1 P28482 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PDK2 Q15119 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
TP53 P04637 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
GRM5 P41594 1/20 0.30
LMNA P02545 1/20 0.30
PKM P14618 1/20 0.30
KLF5 Q13887 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25878602 0.88 NPC1 (0.31) TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL23606036 0.88 PLA2G2A (0.33) PIM1PIM3PIM2
SCHEMBL23605780 0.88 HTT (0.32) ALDH1A1MAPTLMNA
SCHEMBL25879221 0.86 PLA2G2A (0.34) TSHRHSD17B10MAPK1SMN1; SMN2NPC1
SCHEMBL25878391 0.85 PLA2G2A (0.36) TSHRHSD17B10MAPK1SMN1; SMN2NPC1
SCHEMBL25038146 0.85 KDM4E (0.35) TSHRHSD17B10MAPK1KDM4EALDH1A1
SCHEMBL25038050 0.84 KDM4E (0.36) TSHRHSD17B10MAPK1SMN1; SMN2KDM4E
SCHEMBL23606115 0.84 PLA2G2A (0.34) TSHRHSD17B10PDK2KDM4EALDH1A1
SCHEMBL23605940 0.84 HTT (0.33) TSHRHSD17B10MAPK1SMN1; SMN2NPC1
SCHEMBL25038022 0.83 TSHR (0.34) TSHRHSD17B10MAPK1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM TSHR 3868/4885HSD17B10 2263/4885MAPK1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.